Topical Hemocoagulase for wound healing

Effectiveness of hemocoagulase on the healing of surgical wounds in the neck- a randomized clinical trial

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/11/029267

Enrollment

Registered

2020-11-20

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C109- Malignant neoplasm of oropharynx,unspecified

Interventions

Intervention1: Topical hemocoagulase for improving wound healing: topical preparation that is prepared from snake venom contains extracted hemocoagulase. The preparation of topical solution in each ml

Eligibility

Inclusion criteria

Inclusion criteria: Patients undergoing surgery as the primary modality of treatment for head and neck tumor. Patients undergoing neck dissection for the surgical management of head and neck tumor.

Exclusion criteria

Exclusion criteria: Patients with history of systemic disease, CVS disease, Asthma, Hypertension, Diabetes, Coagulopathy, Bleeding disorder, Vascular anomaly, Anticoagulant therapy, Hypersensitivity to hemocoagulase and other constituents of the formulation.

Design outcomes

Primary

Measure	Time frame
Scar thickness Scar Elasticity Patient Observer Scar Assessment Scale (POSAS)Timepoint: 7th day 4th week	—

Secondary

Measure	Time frame
Patient Observer Scar Assessment Scale (POSAS)Timepoint: 7th post operative day and 4th post operative week	—

Countries

India

Contacts

Public ContactDyna Albert

Saveetha Dental College

profdrmuthusekhar@gmail.com9841018236

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026